BNP/CALL/ASTRAZENECA/10500/0.1/20.12.24 Stock

DE000PC3BU33

Market Closed - Boerse Frankfurt Warrants 11:20:57 2024-05-31 EDT
2.56 ^EUR	+6.22%

Current month	+4.92%
1 month	+4.92%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart ASTRAZENECA PLC

Chart BNP/CALL/ASTRAZENECA/10500/0.1/20.12.24

Latest news about ASTRAZENECA PLC

Health Care Stocks Climb On Drug News -- Health Care Roundup	05-31	DJ
Fusion Pharmaceuticals Gets Court Order Approving AstraZeneca Deal	05-31	MT
News Highlights: Top Company News of the Day - Friday at 1 PM ET	05-31	DJ
News Highlights : Top Company News of the Day - Friday at 11 AM ET	05-31	DJ

More news

Quotes 5-day view

Date	Price	Change
24-05-31	2.56	+6.22%
24-05-30	2.41	+4.78%
24-05-29	2.3	-3.36%
24-05-28	2.38	-11.52%
24-05-24	2.69	-3.58%

Real-time Boerse Frankfurt Warrants

Last update May 31, 2024 at 11:20 am

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	ASTRAZENECA PLC
Issuer	BNP Paribas
WKN	PC3BU3
ISIN	DE000PC3BU33
Date issued	2024-01-16
Strike	10,500 p
Maturity	2024-12-20 (202 Days)
Parity	10 : 1
Emission price	1.44 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	2.81 €
Lowest since issue	0.61 €
Spread	0.02 €
Spread %	0.78%

Company Profile

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).

Sector

More about the company